Trump’s Tariff Plan Could Raise Prices on Botox, Fillers, Cosmetic Surgeries

Trump's decision to impose 145% tariffs from goods in China, effective since April 10, though it is on pause, will pose challenges on supply chains, affordable medication and health-care access.
Trump's decision to impose 145% tariffs from goods in China, effective since April 10, though it is on pause, will pose challenges on supply chains, affordable medication and health-care access.
Courtesy of Rokas at Adobe Stock

President Donald Trump has imposed tariffs on imports from about 90 nations, applying a 10% baseline tax to all imports to the U.S., with some countries’ imports dramatically exceeding that baseline, and while this action was put on pause for 90 days until early July, if this plan carries out, it could affect medspas and practices that depend on medical supplies and devices manufactured overseas, and also their patients.

Log in to view the full article
More in News